SCHEMBL13233349

SCHEMBL13233349

Cc1cc(C=O)ccc1OP

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 11/20 0.52
▸ TSHR P16473 1/20 0.52
▸ AOX1 Q06278 1/20 0.47
▸ FDPS P14324 1/20 0.44
▸ ALDH1A3 P47895 3/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ TRIM24 O15164 1/20 0.43
▸ ALDH5A1 P51649 1/20 0.43
▸ ABAT P80404 1/20 0.43
▸ TRIM33 Q9UPN9 1/20 0.43
▸ CYP2A6 P11509 2/20 0.41
▸ TTR P02766 1/20 0.41
▸ SRC P12931 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.37
▸ MAPT P10636 2/20 0.37
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19849522 0.83 ALDH1A1 (0.55) ALDH1A1TSHRAOX1FDPSALDH1A3
SCHEMBL493442 0.82 ALDH1A1 (0.70) ALDH1A1TSHRAOX1FDPSALDH1A3
SCHEMBL13578674 0.80 ALDH1A1 (0.52) ALDH1A1TSHRAOX1FDPSALDH1A3
SCHEMBL14823101 0.78 ALDH1A1 (0.78) ALDH1A1TSHRAOX1FDPSALDH1A3
SCHEMBL6480086 0.78 ALDH1A1 (0.50) ALDH1A1TSHRAOX1FDPSALDH1A3
SCHEMBL4702952 0.78 FDPS (0.51) ALDH1A1TSHRAOX1FDPSTDP1
SCHEMBL12476044 0.77 ALDH1A3 (0.53) ALDH1A1TSHRAOX1FDPSALDH1A3
SCHEMBL17693601 0.77 ALDH1A1 (0.48) ALDH1A1TSHRAOX1FDPSALDH1A3
SCHEMBL3721435 0.77 ALDH1A1 (0.62) ALDH1A1TSHRAOX1FDPSTDP1
SCHEMBL15580939 0.77 ALDH1A1 (0.53) ALDH1A1TSHRAOX1FDPSALDH1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168151-A1 NOVEL PROCESSES FOR PREPARING 6-(DIFLUOROMETHOXY)[1]BENZOFURO[3,2-C]PYRIDINE-9-CARBALDEHYDE, A NOVEL INTERMEDIATE FOR THE SYNTHESIS OF PDE IV INHIBITORS GLENMARK PHARMACEUTICALS, S.A. (CH) 2010-07-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168151-A1 NOVEL PROCESSES FOR PREPARING 6-(DIFLUOROMETHOXY)[1]BENZOFURO[3,2-C]PYRIDINE-9-CARBALDEHYDE, A NOVEL INTERMEDIATE FOR THE SYNTHESIS OF PDE IV INHIBITORS PDE4B, PDE4A, PDE4C ALDH1A1 341/4885TSHR 3854/4885AOX1 247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback